Home › NDC Lookup › RxCUI directory › RxCUI 894863

Acitretin 22.5 MG Oral Capsule — RxCUI 894863

RxNorm drug concept · Semantic clinical drug
RxCUI 894863 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI894863
Official nameAcitretin 22.5 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped4
Package NDCs mapped4
Reported Medicaid activity (SDUD)1,098 prescriptions · 16 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Acitretin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Acitretin is a retinoid — a vitamin A-related compound — that helps slow down the out-of-control skin cell growth that causes psoriasis plaques. It's used for severe psoriasis when...
  • What exactly is acitretin supposed to do for my psoriasis?
  • Yes, it really does matter. Taking acitretin with your main meal — not just a snack — significantly improves how much of the drug your body actually absorbs. All the clinical studi...
  • Why do I have to take this with food, and does it matter how much I eat?
📖 Read our full Acitretin guide →

🕸️ Concept Web — How Acitretin 22.5 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Acitretin 22.5 MG Oral Capsule RxCUI 894863

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Acitretin 16818
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Acitretin Oral Capsule 370533
    • Acitretin Oral Product 1153162
    • Acitretin Pill 1153163
    • Oral Capsule 316965
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Acitretin 22.5 MG 894862

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Acitretin 22.5 MG SCDC · 894862
  • Acitretin Oral Capsule SCDF · 370533
  • Acitretin Oral Product SCDG · 1153162
  • Acitretin Pill SCDG · 1153163

📦 FDA Products & Package NDCs

4 products · 4 package NDCs
4 package NDCs map to RxCUI 894863 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00115-1750-08 30 CAPSULE in 1 BOTTLE, PLASTIC (0115-1750-08) Acitretin Amneal Pharmaceuticals of New York LLC 2016-01-04
00115-1751-08 30 CAPSULE in 1 BOTTLE, PLASTIC (0115-1751-08) Acitretin Amneal Pharmaceuticals of New York LLC 2016-01-04
00115-1752-08 30 CAPSULE in 1 BOTTLE, PLASTIC (0115-1752-08) Acitretin Amneal Pharmaceuticals of New York LLC 2016-01-04
00115-1753-08 30 CAPSULE in 1 BOTTLE, PLASTIC (0115-1753-08) Acitretin Amneal Pharmaceuticals of New York LLC 2016-01-04
Observed labelers: Amneal Pharmaceuticals of New York LLC (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.